SunLink Health Systems, Inc. Logo

SunLink Health Systems, Inc.

SSY

(1.5)
Stock Price

0,77 USD

-7.86% ROA

-5.23% ROE

-3.64x PER

Market Cap.

5.562.074,00 USD

3.31% DER

0% Yield

-2.3% NPM

SunLink Health Systems, Inc. Stock Analysis

SunLink Health Systems, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

SunLink Health Systems, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.3x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (6%), which means it has a small amount of debt compared to the ownership it holds

3 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

4 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (58), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

5 ROE

The stock's ROE indicates a negative return (-9.17%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-7.62%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

SunLink Health Systems, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

SunLink Health Systems, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

SunLink Health Systems, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

SunLink Health Systems, Inc. Revenue
Year Revenue Growth
1986 90.800.000
1987 119.500.000 24.02%
1988 143.700.000 16.84%
1989 84.700.000 -69.66%
1990 89.800.000 5.68%
1991 105.900.000 15.2%
1992 99.100.000 -6.86%
1993 97.200.000 -1.95%
1994 90.200.000 -7.76%
1995 91.800.000 1.74%
1996 95.800.000 4.18%
1997 111.700.000 14.23%
1998 93.700.000 -19.21%
1999 50.300.000 -86.28%
2000 32.011.000 -57.13%
2001 41.674.000 23.19%
2002 87.457.000 52.35%
2003 99.201.000 11.84%
2004 112.436.000 11.77%
2005 128.732.000 12.66%
2006 135.576.000 5.05%
2007 143.645.000 5.62%
2008 158.431.000 9.33%
2009 199.254.000 20.49%
2010 197.784.000 -0.74%
2011 181.161.000 -9.18%
2012 146.674.000 -23.51%
2013 108.225.000 -35.53%
2014 105.430.000 -2.65%
2015 91.833.000 -14.81%
2016 63.433.000 -44.77%
2017 53.288.000 -19.04%
2018 52.872.000 -0.79%
2019 45.618.000 -15.9%
2020 47.813.000 4.59%
2021 40.685.000 -17.52%
2022 41.344.000 1.59%
2023 47.949.000 13.78%
2024 31.652.000 -51.49%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

SunLink Health Systems, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

SunLink Health Systems, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 8.800.000 100%
1996 9.200.000 4.35%
1997 9.400.000 2.13%
1998 8.800.000 -6.82%
1999 8.500.000 -3.53%
2000 3.949.000 -115.24%
2001 0 0%
2002 64.293.000 100%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 27.759.000 100%
2010 3.316.000 -737.12%
2011 3.172.000 -4.54%
2012 66.038.000 95.2%
2013 54.578.000 -21%
2014 52.871.000 -3.23%
2015 44.462.000 -18.91%
2016 31.574.000 -40.82%
2017 23.939.000 -31.89%
2018 24.177.000 0.98%
2019 19.800.000 -22.11%
2020 20.164.000 1.81%
2021 14.350.000 -40.52%
2022 19.558.000 26.63%
2023 19.693.000 0.69%
2024 10.864.000 -81.27%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

SunLink Health Systems, Inc. EBITDA
Year EBITDA Growth
1986 3.600.000
1987 -4.900.000 173.47%
1988 2.800.000 275%
1989 600.000 -366.67%
1990 200.000 -200%
1991 6.500.000 96.92%
1992 3.800.000 -71.05%
1993 3.500.000 -8.57%
1994 3.200.000 -9.38%
1995 4.300.000 25.58%
1996 4.000.000 -7.5%
1997 7.000.000 42.86%
1998 -1.800.000 488.89%
1999 -2.900.000 37.93%
2000 -474.000 -511.81%
2001 -156.000 -203.85%
2002 3.668.000 104.25%
2003 7.378.000 50.28%
2004 8.307.000 11.18%
2005 10.064.000 17.46%
2006 11.027.000 8.73%
2007 8.814.000 -25.11%
2008 11.184.000 21.19%
2009 13.058.000 14.35%
2010 9.739.000 -34.08%
2011 10.852.000 10.26%
2012 2.396.000 -352.92%
2013 3.743.000 35.99%
2014 3.622.000 -3.34%
2015 4.215.000 14.07%
2016 -3.229.000 230.54%
2017 -1.096.000 -194.62%
2018 808.000 235.64%
2019 -435.000 285.75%
2020 1.175.000 137.02%
2021 2.955.000 60.24%
2022 -6.817.000 143.35%
2023 -587.000 -1061.33%
2024 -1.048.000 43.99%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

SunLink Health Systems, Inc. Gross Profit
Year Gross Profit Growth
1986 15.200.000
1987 16.200.000 6.17%
1988 22.600.000 28.32%
1989 12.900.000 -75.19%
1990 11.700.000 -10.26%
1991 15.800.000 25.95%
1992 13.300.000 -18.8%
1993 13.600.000 2.21%
1994 12.900.000 -5.43%
1995 13.600.000 5.15%
1996 13.300.000 -2.26%
1997 16.000.000 16.88%
1998 9.200.000 -73.91%
1999 4.500.000 -104.44%
2000 3.497.000 -28.68%
2001 15.737.000 77.78%
2002 68.293.000 76.96%
2003 66.166.000 -3.21%
2004 38.510.000 -71.82%
2005 44.729.000 13.9%
2006 45.577.000 1.86%
2007 48.610.000 6.24%
2008 55.432.000 12.31%
2009 62.383.000 11.14%
2010 60.733.000 -2.72%
2011 56.149.000 -8.16%
2012 101.352.000 44.6%
2013 69.287.000 -46.28%
2014 67.532.000 -2.6%
2015 58.133.000 -16.17%
2016 36.455.000 -59.47%
2017 28.760.000 -26.76%
2018 29.848.000 3.65%
2019 22.928.000 -30.18%
2020 24.651.000 6.99%
2021 21.611.000 -14.07%
2022 20.106.000 -7.49%
2023 23.899.000 15.87%
2024 12.756.000 -87.35%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

SunLink Health Systems, Inc. Net Profit
Year Net Profit Growth
1986 2.000.000
1987 -2.000.000 200%
1988 500.000 500%
1989 1.100.000 54.55%
1990 -4.900.000 122.45%
1991 2.200.000 322.73%
1992 1.500.000 -46.67%
1993 2.600.000 42.31%
1994 1.400.000 -85.71%
1995 2.000.000 30%
1996 1.200.000 -66.67%
1997 2.100.000 42.86%
1998 300.000 -600%
1999 -8.600.000 103.49%
2000 1.583.000 643.27%
2001 478.000 -231.17%
2002 833.000 42.62%
2003 553.000 -50.63%
2004 13.425.000 95.88%
2005 4.540.000 -195.7%
2006 3.909.000 -16.14%
2007 1.396.000 -180.01%
2008 1.616.000 13.61%
2009 912.000 -77.19%
2010 102.000 -794.12%
2011 -10.715.000 100.95%
2012 1.081.000 1091.21%
2013 4.488.000 75.91%
2014 -545.000 923.49%
2015 245.000 322.45%
2016 -14.083.000 101.74%
2017 2.688.000 623.92%
2018 -1.593.000 268.74%
2019 -1.996.000 20.19%
2020 -586.000 -240.61%
2021 6.890.000 108.51%
2022 -1.722.000 500.12%
2023 -1.795.000 4.07%
2024 17.152.000 110.47%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

SunLink Health Systems, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 -1 100%
1991 0 0%
1992 0 0%
1993 1 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 -2 100%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 2 100%
2005 1 0%
2006 1 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 -1 100%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -1 100%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 1 100%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

SunLink Health Systems, Inc. Free Cashflow
Year Free Cashflow Growth
1991 500.000
1992 -1.200.000 141.67%
1993 3.100.000 138.71%
1994 -400.000 875%
1995 800.000 150%
1996 2.200.000 63.64%
1997 2.400.000 8.33%
1998 2.500.000 4%
1999 -1.500.000 266.67%
2000 -3.966.000 62.18%
2001 -2.298.000 -72.58%
2002 -2.122.000 -8.29%
2003 243.000 973.25%
2004 -4.539.000 105.35%
2005 -1.804.000 -151.61%
2006 -3.506.000 48.55%
2007 -4.288.000 18.24%
2008 -6.657.000 35.59%
2009 2.859.000 332.84%
2010 1.426.000 -100.49%
2011 2.139.000 33.33%
2012 1.068.000 -100.28%
2013 -6.991.000 115.28%
2014 2.169.000 422.31%
2015 1.636.000 -32.58%
2016 -1.773.000 192.27%
2017 -7.240.000 75.51%
2018 -1.465.000 -394.2%
2019 -2.699.000 45.72%
2020 2.784.000 196.95%
2021 -1.230.000 326.34%
2022 -3.194.000 61.49%
2023 -2.540.000 -25.75%
2024 -764.000 -232.46%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

SunLink Health Systems, Inc. Operating Cashflow
Year Operating Cashflow Growth
1991 3.400.000
1992 2.700.000 -25.93%
1993 4.300.000 37.21%
1994 400.000 -975%
1995 1.200.000 66.67%
1996 2.500.000 52%
1997 3.000.000 16.67%
1998 7.800.000 61.54%
1999 -600.000 1400%
2000 -3.751.000 84%
2001 -1.304.000 -187.65%
2002 3.514.000 137.11%
2003 243.000 -1346.09%
2004 -2.660.000 109.14%
2005 2.225.000 219.55%
2006 4.506.000 50.62%
2007 4.749.000 5.12%
2008 1.680.000 -182.68%
2009 4.430.000 62.08%
2010 3.928.000 -12.78%
2011 4.779.000 17.81%
2012 3.082.000 -55.06%
2013 -2.016.000 252.88%
2014 3.892.000 151.8%
2015 2.938.000 -32.47%
2016 -426.000 789.67%
2017 -5.610.000 92.41%
2018 396.000 1516.67%
2019 -1.427.000 127.75%
2020 3.969.000 135.95%
2021 1.365.000 -190.77%
2022 -4.000 34225%
2023 -540.000 99.26%
2024 -386.000 -39.9%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

SunLink Health Systems, Inc. Capital Expenditure
Year Capital Expenditure Growth
1991 2.900.000
1992 3.900.000 25.64%
1993 1.200.000 -225%
1994 800.000 -50%
1995 400.000 -100%
1996 300.000 -33.33%
1997 600.000 50%
1998 5.300.000 88.68%
1999 900.000 -488.89%
2000 215.000 -318.6%
2001 994.000 78.37%
2002 5.636.000 82.36%
2003 0 0%
2004 1.879.000 100%
2005 4.029.000 53.36%
2006 8.012.000 49.71%
2007 9.037.000 11.34%
2008 8.337.000 -8.4%
2009 1.571.000 -430.68%
2010 2.502.000 37.21%
2011 2.640.000 5.23%
2012 2.014.000 -31.08%
2013 4.975.000 59.52%
2014 1.723.000 -188.74%
2015 1.302.000 -32.33%
2016 1.347.000 3.34%
2017 1.630.000 17.36%
2018 1.861.000 12.41%
2019 1.272.000 -46.31%
2020 1.185.000 -7.34%
2021 2.595.000 54.34%
2022 3.190.000 18.65%
2023 2.000.000 -59.5%
2024 378.000 -429.1%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

SunLink Health Systems, Inc. Equity
Year Equity Growth
1986 11.700.000
1987 13.600.000 13.97%
1988 16.900.000 19.53%
1989 11.300.000 -49.56%
1990 5.800.000 -94.83%
1991 8.500.000 31.76%
1992 10.200.000 16.67%
1993 9.900.000 -3.03%
1994 10.600.000 6.6%
1995 14.100.000 24.82%
1996 14.500.000 2.76%
1997 18.000.000 19.44%
1998 18.100.000 0.55%
1999 7.500.000 -141.33%
2000 9.513.000 21.16%
2001 9.631.000 1.23%
2002 5.955.000 -61.73%
2003 6.473.000 8%
2004 24.904.000 74.01%
2005 29.301.000 15.01%
2006 34.352.000 14.7%
2007 36.024.000 4.64%
2008 40.859.000 11.83%
2009 42.392.000 3.62%
2010 42.692.000 0.7%
2011 31.456.000 -35.72%
2012 29.291.000 -7.39%
2013 33.743.000 13.19%
2014 33.318.000 -1.28%
2015 33.560.000 0.72%
2016 19.489.000 -72.2%
2017 21.693.000 10.16%
2018 17.186.000 -26.22%
2019 15.043.000 -14.25%
2020 13.743.000 -9.46%
2021 20.810.000 33.96%
2022 19.120.000 -8.84%
2023 17.417.000 -9.78%
2024 15.973.000 -9.04%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

SunLink Health Systems, Inc. Assets
Year Assets Growth
1986 50.400.000
1987 65.400.000 22.94%
1988 79.000.000 17.22%
1989 51.900.000 -52.22%
1990 42.500.000 -22.12%
1991 45.200.000 5.97%
1992 46.400.000 2.59%
1993 46.000.000 -0.87%
1994 43.200.000 -6.48%
1995 44.200.000 2.26%
1996 42.400.000 -4.25%
1997 50.000.000 15.2%
1998 39.600.000 -26.26%
1999 29.700.000 -33.33%
2000 23.128.000 -28.42%
2001 56.514.000 59.08%
2002 48.571.000 -16.35%
2003 8.807.000 -451.5%
2004 63.152.000 86.05%
2005 65.440.000 3.5%
2006 74.303.000 11.93%
2007 77.843.000 4.55%
2008 111.624.000 30.26%
2009 107.383.000 -3.95%
2010 98.490.000 -9.03%
2011 89.536.000 -10%
2012 79.172.000 -13.09%
2013 68.003.000 -16.42%
2014 63.847.000 -6.51%
2015 57.128.000 -11.76%
2016 44.841.000 -27.4%
2017 35.336.000 -26.9%
2018 26.176.000 -34.99%
2019 24.419.000 -7.2%
2020 27.971.000 12.7%
2021 31.564.000 11.38%
2022 27.943.000 -12.96%
2023 23.269.000 -20.09%
2024 20.612.000 -12.89%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

SunLink Health Systems, Inc. Liabilities
Year Liabilities Growth
1986 38.700.000
1987 51.800.000 25.29%
1988 62.100.000 16.59%
1989 40.600.000 -52.96%
1990 36.700.000 -10.63%
1991 36.700.000 0%
1992 36.200.000 -1.38%
1993 36.100.000 -0.28%
1994 32.600.000 -10.74%
1995 30.100.000 -8.31%
1996 27.900.000 -7.89%
1997 32.000.000 12.81%
1998 21.500.000 -48.84%
1999 22.200.000 3.15%
2000 13.615.000 -63.06%
2001 46.883.000 70.96%
2002 42.616.000 -10.01%
2003 2.334.000 -1725.88%
2004 38.248.000 93.9%
2005 36.139.000 -5.84%
2006 39.951.000 9.54%
2007 41.819.000 4.47%
2008 70.765.000 40.9%
2009 64.991.000 -8.88%
2010 55.798.000 -16.48%
2011 58.080.000 3.93%
2012 49.881.000 -16.44%
2013 34.260.000 -45.6%
2014 30.529.000 -12.22%
2015 23.568.000 -29.54%
2016 25.352.000 7.04%
2017 13.643.000 -85.82%
2018 8.990.000 -51.76%
2019 9.376.000 4.12%
2020 14.228.000 34.1%
2021 10.754.000 -32.3%
2022 8.823.000 -21.89%
2023 5.852.000 -50.77%
2024 4.639.000 -26.15%

SunLink Health Systems, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
4.61
Net Income per Share
-0.22
Price to Earning Ratio
-3.64x
Price To Sales Ratio
0.17x
POCF Ratio
-1.87
PFCF Ratio
-1.25
Price to Book Ratio
0.35
EV to Sales
-0.03
EV Over EBITDA
1.04
EV to Operating CashFlow
0.36
EV to FreeCashFlow
0.24
Earnings Yield
-0.27
FreeCashFlow Yield
-0.8
Market Cap
0,01 Bil.
Enterprise Value
0,00 Bil.
Graham Number
3.33
Graham NetNet
0.83

Income Statement Metrics

Net Income per Share
-0.22
Income Quality
1.8
ROE
-0.11
Return On Assets
-0.04
Return On Capital Employed
-0.2
Net Income per EBT
0.31
EBT Per Ebit
0.74
Ebit per Revenue
-0.1
Effective Tax Rate
-0.04

Margins

Sales, General, & Administrative to Revenue
0.34
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.28
Operating Profit Margin
-0.1
Pretax Profit Margin
-0.07
Net Profit Margin
-0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.42
Free CashFlow per Share
-0.63
Capex to Operating CashFlow
-0.49
Capex to Revenue
0.05
Capex to Depreciation
2.27
Return on Invested Capital
0.17
Return on Tangible Assets
-0.08
Days Sales Outstanding
37.93
Days Payables Outstanding
29.96
Days of Inventory on Hand
24.42
Receivables Turnover
9.62
Payables Turnover
12.18
Inventory Turnover
14.95
Capex per Share
0.21

Balance Sheet

Cash per Share
1,02
Book Value per Share
2,27
Tangible Book Value per Share
2.1
Shareholders Equity per Share
2.27
Interest Debt per Share
0.08
Debt to Equity
0.03
Debt to Assets
0.03
Net Debt to EBITDA
6.39
Current Ratio
3.72
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
15956000
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.06
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
1557000
Debt to Market Cap
0.09

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

SunLink Health Systems, Inc. Dividends
Year Dividends Growth
1989 0
1993 0 0%

SunLink Health Systems, Inc. Profile

About SunLink Health Systems, Inc.

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.

CEO
Mr. Robert M. Thornton Jr.
Employee
1.376
Address
900 Circle 75 Parkway
Atlanta, 30339

SunLink Health Systems, Inc. Executives & BODs

SunLink Health Systems, Inc. Executives & BODs
# Name Age
1 Mr. Byron D. Finn CPA
President of SunLink ScriptsRX, LLC & Carmichaels Cashway Pharmacy Inc
70
2 Neal Miller
President of SunLink HealthCare Technology, Inc
70
3 Ms. Sheila G. Brockman
Vice President
70
4 Mr. James J. Mulligan
General Counsel & Director Emeritus
70
5 Ms. Theresa Mota
Secretary
70
6 Mr. Robert M. Thornton Jr.
Executive Chairman, Chief Executive Officer & President
70
7 Mr. Mark J. Stockslager
Chief Financial Officer, Principal Accounting Officer & Director
70

SunLink Health Systems, Inc. Competitors